Developing new ways to prevent and treat endometrial cancer
Route 66 Endometrial Cancer SPORE
['FUNDING_OTHER'] · WASHINGTON UNIVERSITY · NIH-11128242
This study is looking for new ways to prevent and treat endometrial cancer, and it's inviting women who are at risk or affected by this cancer to join in clinical trials to help test these exciting new treatments.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-11128242 on ClinicalTrials.gov |
What this research studies
The Route 66 Endometrial Cancer SPORE focuses on creating innovative strategies to prevent and treat endometrial cancer through collaborative research across three institutions. It includes multiple projects that explore the role of specific proteins in cancer therapy, improve treatment responses, and enhance prevention methods for women at risk. Patients may participate in clinical trials that test these new therapies and approaches, contributing to advancements in cancer care. The research also emphasizes the importance of biostatistics and bioinformatics in analyzing patient data to inform treatment decisions.
Who could benefit from this research
Good fit: Ideal candidates for participation include women diagnosed with endometrial cancer or those at high risk due to conditions like obesity and endometrial hyperplasia.
Not a fit: Patients with other types of cancer or those not diagnosed with endometrial cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and preventive measures for endometrial cancer, improving patient outcomes.
How similar studies have performed: Previous research has shown promise in similar approaches to cancer treatment and prevention, indicating potential for success in this area.
Where this research is happening
SAINT LOUIS, UNITED STATES
- WASHINGTON UNIVERSITY — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MUTCH, DAVID G — WASHINGTON UNIVERSITY
- Study coordinator: MUTCH, DAVID G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.